These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6291831)

  • 1. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
    Escobar E; Ojeda G; Saavedra M; Thumala A
    Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of captopril in circulatory failure].
    Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
    Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
    Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
    [No Abstract]   [Full Text] [Related]  

  • 6. [Captopril in the treatment of refractory cardiac insufficiency].
    Gorb IuG
    Ter Arkh; 1985; 57(12):63-7. PubMed ID: 3911466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
    Rahn KH; Stumpe KO
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of the renin-angiotensin system in the regulation of the vascular resistance of chronic heart failure (author's transl)].
    Noda H; Tokuyasu Y; Takahahashi S; Nakao H; Kimata S; Hirosawa K; Sugino N
    Kokyu To Junkan; 1981 Sep; 29(9):971-6. PubMed ID: 7034102
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of prostaglandins and kinin-kallikrein system in heart failure].
    Yui Y; Kawai C
    Nihon Rinsho; 1983 Dec; 41(12):2735-9. PubMed ID: 6325759
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic changes during captopril inhibition of the renin-angiotensin-aldosterone system in patients with circulatory failure following heart valve prosthesis].
    Anokhin VN; Vladimirov PV; Marshutin NA; Migalina LA; Zenkov VE
    Revmatologiia (Mosk); 1988; (2):43-8. PubMed ID: 3051276
    [No Abstract]   [Full Text] [Related]  

  • 12. Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.
    Packer M
    Int J Cardiol; 1985 Feb; 7(2):111-20. PubMed ID: 2982750
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute and chronic effects of captopril therapy in patients with refractory heart failure.
    Walsh WF; Lee CL
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):153S-159S. PubMed ID: 6753896
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone and haemodynamic effects of angiotensin II infusion during captopril treatment for heart failure.
    Chambers S; Nicholls MG; Espiner EA; Ikram H; Livesey JH
    Horm Metab Res; 1985 Mar; 17(3):159-62. PubMed ID: 2987094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
    Maslowski AH; Ikram H; Nicholls MG; Espiner EA
    Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
    Turini GA; Waeber B; Brunner HR
    Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of captopril on pulmonary arterial hypertension in congestive heart failure associated with chronic obstructive bronchopneumopathy].
    Saadjian A; Philip-Joet F; Allard-Latour G; Arnaud A; Torresani J
    Rev Pneumol Clin; 1984; 40(5):321-5. PubMed ID: 6395282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
    Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
    Cody RJ; Laragh JH
    Am Heart J; 1982 Nov; 104(5 Pt 2):1184-9. PubMed ID: 6291364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
    Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.